Management and Board


Tomas J. Svoboda BSc, MBA

CEO, Chief Executive Officer

In his 28 years in the life science industry, Mr Svoboda has worked in leading medical device, in-vitro diagnostic, and drug delivery/combination product companies, such as Serono, Haemonetics and Boston Scientific. Since 2000, he has been involved in various start-ups, as CEO and other senior management positions.

Egon Minar

COO, Chief Operating Officer /CFO, Chief Financial Officer

Egon Minar has over 40 years of senior operational and financial management experience. Held CEO roles at Hamburg-based Navigon AG and Nuremberg-based AEG GmbH/Electrolux GmbH, successive executive positions at Sony in Europe, at Munich-based OWR Rodenstock and latest at Swiss-based Cafina AG. He has extensive experience in management consultancy and supervisory board memberships for multiple companies.


CTO, Chief Technology Officer

Over 20 years of experience in academic and industrial environments.
As Laboratory Head for Cardiovascular Tissue Engineering at the CEHA (KULeuven), Dr. De Visscher developed the technology that was transferred to Anethon, a company he co-founded and where he served as CSO. Subsequently, he served as Head of Research and Development at Nitto Denko’s Swiss R&D center based in Lausanne.
Dr. De Visscher holds a Master in Biology from the Vrije Universiteit Brussel (Belgium), a Ph.D. from the University of Maastricht (Netherlands) and an executive MBA from IMD, Lausanne (Switzerland).


Business Development & Partnering Manager

Broad experience in Telecommunication, Office Lease Services, Paramedical industries in various Commercial & Finance Management positions.
Acting as Senior Advisor or Consultant in Partnering Business Development, Commercial Operation, Channel Management, Customer investments and Compensation programs.

Board of directors

Jürgen F. Kullmann (Chairman)

Pursuant to his 20 year career in Sales and Marketing, Mr. Jürgen Kullmann has been acting as an independent consultant and interim manager on executive level since 1995. He held several executive and supervisory board positions and currently holds the position as a Member of Board at Alexanderwerk AG. As a Chief Restructuring Officer he also manages the turnaround of a larger Swiss event organisation.

Abigael de Buys Roessingh

During last nine years Mrs. de Buys Roessingh has provided analytical, strategic and economic expertise to help manage Charities and Foundations of which one is active in medical research.

Currently she is presiding over two non-profit organizations and on the executive board of another company.


Mr Voigt is currently CEO and Executive Director of Prima BioMed Ltd. and  has held various Executive or Supervisory Board positions in the past.

Team members

Annick Jeannerat PhD

R&D Manager (Cell Based Therapy)

Dr. Jeannerat holds a Ph.D. in life science from the University of Lausanne. She has over 10 years of experience in academia and the Life Science Industry with expertise in assay development, inflammation and wound healing.



Over 5 years of experience working in the Pharmaceutical and Medical Devices Industry in areas such as Regulatory Affairs, Marketing and Sales.

Marianne Sengupta

Office Manager

Over 15 years of experience in the area of Company & Fiduciary Administration, Client relations, Compliance within Private banking, Trust & Wealth Management. Since 2012 active in Office Management and Business support.